Form 4: Denali Therapeutics' Chief Medical Officer Carole Ho Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Carole Ho, Chief Medical Officer of Denali Therapeutics, sold 2,337 shares of common stock on August 13, 2024, to satisfy tax obligations related to vested restricted stock units.
Summary
- On August 13, 2024, Carole Ho, the Chief Medical Officer of Denali Therapeutics Inc., sold 2,337 shares of the company's common stock.
- The sale was executed at a price of $22.89 per share.
- This transaction was conducted to cover tax obligations arising from the settlement of previously vested restricted stock units.
- Following the transaction, Carole Ho directly owns 141,268 shares, which includes 123,810 RSUs.
- She also indirectly owns 183,219 shares through the Rohatgi-Ho Family 2009 Revocable Trust, where she serves as trustee, and 25,000 shares through The Rohatgi-Ho Irrevocable GST Trust for the benefit of her children.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (stock sale for tax obligations) and doesn't contain information that would significantly shift investor sentiment positively or negatively.
Industry Context
Sales of shares by company executives are a normal part of corporate activity, often related to compensation and personal financial management. It is important to consider the size of the sale relative to the executive's total holdings in the company.
Key Dates
| Date | Description |
|---|---|
| 08/13/2024 | Date of stock sale transaction. |
| 08/15/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.